2 / 14
Volume 9
Journal of Addiction Research & Therapy
Addiction 2018
November 12-13, 2018
Page 26
conference
series
.com
November 12-13, 2018 Dubai, UAE
9
th
International Conference on
Addiction & Psychiatry
New drugs of abuse: What clinicians need to know?
D
rug abuse is a growing concern all over the world and over the past decade, novel drugs have emerged and have become
increasingly popular. Designer drugs otherwise known as synthetic drugs-are manufactured to chemically resemble illicit
drugs, but may be purchased legally because drug manufacturers constantly change the chemical structure to circumvent
drug laws. In fact, designer synthetic drugs are found to be more potent and dangerous than their street drug counterparts.
People who abuse designer synthetic drugs have suffered a number of negative health outcomes that include anxiety, seizures,
hallucinations, loss of consciousness and significant organ damage. Recognition and treatment of new drugs of abuse pose
many challenges for health care providers due to lack of quantitative reporting and the difficulty of detection in routine blood
and urine analyses. Clinicians should familiarize themselves with management principles of these new agents. Therefore, the
purpose of this workshop is to describe the pharmacology, clinical and adverse effects of several new classes of drugs of abuse
as well as management of patients with addiction to these drugs.
Biography
Amany Haroun El Rasheed was a Professor in Psychiatry, Faculty of Medicine at Ain Shams University. She is currently working as a Consultant Psychiatrist at
Al Amal Hospital, Ministry of Health, Dubai, UAE. She was a NIDA (National Institute of Drug Abuse) Hubert H. Humphrey Drug Abuse Research Fellow in Johns
Hopkins University.
amanyhelrasheed@gmail.comAmany Haroun El Rasheed
Al Amal Psychiatric Hospital, UAE
Amany Haroun El Rasheed, J Addict Res Ther 2018, Volume 9
DOI: 10.4172/2155-6105-C3-042